Home
About
Overview
Sharing Data
ORCID
Help
History (76)
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial.
Human allograft rejection in humanized mice: a historical perspective.
Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
Younger stroke survivors have reduced access to physician care and medications: National Health Interview Survey from years 1998 to 2002.
A mutant cell with a novel defect in MHC class I quality control.
See All 76 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A mutant cell with a novel defect in MHC class I quality control.
York IA, Grant EP, Dahl AM, Rock KL. A mutant cell with a novel defect in MHC class I quality control. J Immunol. 2005 Jun 01; 174(11):6839-46.
View in:
PubMed
subject areas
Animals
beta 2-Microglobulin
Cell Membrane
COS Cells
Down-Regulation
Endoplasmic Reticulum
H-2 Antigens
Humans
Mice
Molecular Chaperones
Mutagenesis
Protein Processing, Post-Translational
Quality Control
authors with profiles
Kenneth L Rock MD